Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
1.61
-0.03 (-1.84%)
Bozor ochiq: Aug 12, 2026, 12:10 PM EDT
1.66
+0.02 (1.49%)
Oldingi bozordan keyin: Aug 11, 2026, 7:31 PM EDT
Calidi Biotherapeutics, Inc., biotexnologiya kompaniyasi, kasallikning distal joylariga genetik dorilarni etkazib berish uchun maqsadli davolash usullarini ishlab chiqadi. Kompaniya CLD-101ni taklif etadi, bu yangi tashxis qo'yilgan yuqori darajadagi glial o'smalarini davolash uchun 1b/2-bosqich klinik sinovida, shuningdek, takrorlanuvchi yuqori darajadagi glial o'smalarini davolash uchun 1-bosqich dozani oshirish klinik sinovida; ko'krak bezi saratoni, bosh va bo'yin saratoni va sarkoma kabi qattiq o'smalar uchun CLD-201 mahsuloti; va metastatik qattiq o'smalarni davolash uchun CLD-401. Shuningdek, u NeuroNova va SuperNova kabi onkolitik virus platformalarini taklif etadi. Calidi Biotherapeutics, Inc. 2014 yilda tashkil etilgan va uning shtab-kvartirasi Kaliforniyaning San-Diego shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Antonio Fernandez Santidrian Ph.D., Pharm.D. | Head of Technical Operations & Chief Scientific Officer |
| Dr. Eric E. Poma Ph.D. | CEO & Director |
| Dr. Guy Travis Clifton M.D. | Chief Medical Officer |
| Mr. Andrew C. Jackson | CFO & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-31 | 8-K | form8-k.htm |
| 2026-07-16 | 8-K | form8-k.htm |
| 2026-06-23 | 8-K | form8-k.htm |
| 2026-06-18 | 8-K | form8-k.htm |
| 2026-06-05 | DEFA14A | formdefa14a.htm |
| 2026-05-29 | 8-K | form8-k.htm |
| 2026-05-14 | 8-K | form8-k.htm |
| 2026-05-14 | 10-Q | form10-q.htm |
| 2026-05-08 | 8-K | form8-k.htm |
| 2026-04-29 | DEFA14A | formdefa14a.htm |